(19)
(11) EP 3 999 121 A1

(12)

(43) Date of publication:
25.05.2022 Bulletin 2022/21

(21) Application number: 20839620.0

(22) Date of filing: 14.07.2020
(51) International Patent Classification (IPC): 
A61K 48/00(2006.01)
A61P 3/06(2006.01)
A61P 9/00(2006.01)
C12N 15/861(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 9/00; A61P 3/06; A01K 2227/105; A01K 2217/206; A01K 2217/075; A01K 2267/03; C12N 2750/14143; C12N 2830/008; A01K 2217/15; C12N 15/86; A61K 48/005; A61K 48/0058; C07K 14/78; C12N 15/113; C12N 2310/20
(86) International application number:
PCT/SG2020/050407
(87) International publication number:
WO 2021/010898 (21.01.2021 Gazette 2021/03)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 17.07.2019 SG 10201906637U

(71) Applicants:
  • Agency for Science, Technology and Research
    Singapore 138632 (SG)
  • National University of Singapore
    Singapore 119077 (SG)

(72) Inventors:
  • STEWART, Colin Lawson
    Singapore 138648 (SG)
  • SINGARAJA, Roshni
    Singapore 138648 (SG)
  • BURKE, Brian
    Singapore 138648 (SG)
  • LEE, Yin Loon
    Singapore 138648 (SG)
  • TAN, Yann Chong
    Singapore 138672 (SG)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)

   


(54) TREATMENT/PREVENTION OF DISEASE BY LINC COMPLEX INHIBITION